Annals of Clinical and Translational Neurology

SJR Rank #2,060H-index: 84SJR: 1.645Best quartile: Q1Open AccessAPC: US$4,100Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

John Wiley & Sons Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.511.52

Subject Categories

  • Neurology (clinical)Q1
  • Neuroscience (miscellaneous)Q1

Areas: Medicine · Neuroscience

Most published research topics

Multiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesEpilepsy research and treatmentParkinson's Disease Mechanisms and TreatmentsPeripheral Neuropathies and DisordersNeurological disorders and treatmentsAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAutoimmune Neurological Disorders and Treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025075150225300

Detailed Information

ISSN

2328-9503

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.01

References per Document

35.87

Coverage

2014-2026

Scope

The Annals of Clinical and Translational Neurology (ACTN) publishes articles of broad interest with potential for high impact in understanding the mechanisms and treatment of diseases of the human nervous system. All areas of clinical and basic neuroscience, including new technologies, cellular and molecular neurobiology, population sciences, and studies of behavior, addiction, and psychiatric diseases are of interest to the journal. ACTN is particularly interested in clinical trials and other large-scale studies that inform the practice of medicine. Trials reporting negative data will be considered. The scope of ACTN also includes topics of particular significance in neurologic education as well as other topics of interest to the clinical neuroscience community. In addition to manuscripts from established investigators, ACTN will welcome scholarly work, points-of-view, and case studies from residents, fellows and medical students.

Metrics from SCImago Journal Rank 2025. View on SCImago